Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Dopaminergic Activity and Suicide in Schizophrenia: A Multimodal Neuroimaging Study

EF 2023-24

Résumé
Schizophrenia (SCZ) is a psychiatric disorder that affects 1 in 300 people worldwide and is often characterized by a deteriorating quality of life. The most concerning aspect of SCZ is the devastatingly high suicide risk (SR) and recent study in Ontario revealed that suicide rate in SCZ patients could be 20-fold higher than in heathy individuals. For this reason, there is urgent need to improve suicide prevention, which requires accurate and objective ways of predicting SR. Current suicide assessments rely mainly on patient self-report and physician's judgment, which are affected by bias, stigma, and communication difficulties of the disease itself. Therefore, we aim to find objective and accessible predictors that can identify those at high risk of attempting suicide. Previous studies showed that increased dopamine release in certain brain areas is associated with higher risk of suicide. Additionally, dopamine availability is also affected by a form of DNA modification called DNA methylation (DNAm), which is known to silence certain genes. Hence, our study will use a novel imaging technique called neuromelanin-sensitive magnetic resonance imaging (NM-MRI) as well as DNAm analysis to investigate differences between those at high and low risk of suicide. Using the high accuracy of NM-MRI and the accessibility of blood samples for DNAm analysis, we aim to investigate if dopamine availability in the brain and methylation of dopamine-related genes in the blood can predict the risk of suicide. Ultimately, our goal is to predict suicide risk via a brain scan and/or a simple blood draw. There are currently 12 suicides/day in Canada; this research aims to prioritize patients at high risk to more urgent care in order to improve suicide prevention in this country and worldwide.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506375
Name
Nader George
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Dopaminergic Activity and Suicide in Schizophrenia: A Multimodal Neuroimaging Study
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Dna Methylation; Dopamine Availability; Epigenetics; Genome-Wide Association Studies; Magnetic Resonance Imaging; Neuropsychiatry; Quantitative Neuroimiaging; Schizoaffective Disorder; Schizophrenia; Suicide Prevention
Abstract
Schizophrenia (SCZ) is a psychiatric disorder that affects 1 in 300 people worldwide and is often characterized by a deteriorating quality of life. The most concerning aspect of SCZ is the devastatingly high suicide risk (SR) and recent study in Ontario revealed that suicide rate in SCZ patients could be 20-fold higher than in heathy individuals. For this reason, there is urgent need to improve suicide prevention, which requires accurate and objective ways of predicting SR. Current suicide assessments rely mainly on patient self-report and physician's judgment, which are affected by bias, stigma, and communication difficulties of the disease itself. Therefore, we aim to find objective and accessible predictors that can identify those at high risk of attempting suicide. Previous studies showed that increased dopamine release in certain brain areas is associated with higher risk of suicide. Additionally, dopamine availability is also affected by a form of DNA modification called DNA methylation (DNAm), which is known to silence certain genes. Hence, our study will use a novel imaging technique called neuromelanin-sensitive magnetic resonance imaging (NM-MRI) as well as DNAm analysis to investigate differences between those at high and low risk of suicide. Using the high accuracy of NM-MRI and the accessibility of blood samples for DNAm analysis, we aim to investigate if dopamine availability in the brain and methylation of dopamine-related genes in the blood can predict the risk of suicide. Ultimately, our goal is to predict suicide risk via a brain scan and/or a simple blood draw. There are currently 12 suicides/day in Canada; this research aims to prioritize patients at high risk to more urgent care in order to improve suicide prevention in this country and worldwide.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Nader, George
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~